IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,425,919 | -8.8% | 533,169 | +41.1% | 0.00% | 0.0% |
| Q2 2023 | $2,660,909 | +75.7% | 377,970 | +52.5% | 0.00% | – |
| Q1 2023 | $1,514,772 | +527.3% | 247,917 | +556.0% | 0.00% | – |
| Q4 2022 | $241,484 | -56.7% | 37,791 | -35.2% | 0.00% | – |
| Q3 2022 | $558,000 | +81.2% | 58,320 | +109.4% | 0.00% | – |
| Q2 2022 | $308,000 | -64.5% | 27,849 | -46.6% | 0.00% | – |
| Q1 2022 | $868,000 | -18.7% | 52,126 | -6.8% | 0.00% | – |
| Q4 2021 | $1,068,000 | -12.3% | 55,922 | +13.2% | 0.00% | – |
| Q3 2021 | $1,218,000 | -15.8% | 49,394 | -11.1% | 0.00% | – |
| Q2 2021 | $1,446,000 | -24.8% | 55,566 | -8.5% | 0.00% | – |
| Q1 2021 | $1,923,000 | -42.6% | 60,754 | -15.9% | 0.00% | -100.0% |
| Q4 2020 | $3,352,000 | -12.8% | 72,240 | -38.2% | 0.00% | 0.0% |
| Q3 2020 | $3,845,000 | -14.3% | 116,807 | -28.8% | 0.00% | 0.0% |
| Q2 2020 | $4,489,000 | +39.4% | 164,063 | +52.4% | 0.00% | 0.0% |
| Q1 2020 | $3,221,000 | -44.7% | 107,621 | -56.5% | 0.00% | -50.0% |
| Q4 2019 | $5,825,000 | +60.3% | 247,414 | +23.9% | 0.00% | +100.0% |
| Q3 2019 | $3,634,000 | -20.9% | 199,706 | +6.7% | 0.00% | 0.0% |
| Q2 2019 | $4,592,000 | +28.8% | 187,251 | -50.0% | 0.00% | 0.0% |
| Q1 2019 | $3,564,000 | +68.0% | 374,717 | +56.2% | 0.00% | 0.0% |
| Q4 2018 | $2,122,000 | +19.0% | 239,886 | +51.4% | 0.00% | 0.0% |
| Q3 2018 | $1,783,000 | +68.2% | 158,458 | +91.4% | 0.00% | – |
| Q2 2018 | $1,060,000 | +14.5% | 82,787 | +51.0% | 0.00% | – |
| Q1 2018 | $926,000 | +132.7% | 54,832 | +9.9% | 0.00% | – |
| Q4 2017 | $398,000 | -50.3% | 49,875 | -51.8% | 0.00% | – |
| Q3 2017 | $801,000 | +51.7% | 103,528 | +44.2% | 0.00% | – |
| Q2 2017 | $528,000 | – | 71,804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |